|
In providing the clinical and economic evidence that our clients require, Mapi Values calls on a team of highly skilled and knowledgeable individuals. The senior members of the CEE team have unrivalled expertise in the development and application of appropriate evidence synthesis and economic modelling methodology, as well as in-depth insight into the local and national requirements of HTA and reimbursement authorities. Details of some key members of the team are given below:
Jeanni
van Loon is the Global Lead for the CEE team and the Managing Director in our Netherlands office. Her career has included senior positions in both the pharmaceutical industry and healthcare service companies. She set up the global health economics department of a major pharmaceutical company (Organon) as well as working for the outcomes research consultancy division of an international CRO. Jeanni was involved in revising the pharmacoeconomic guidelines issued by the Dutch authorities and has experience of reimbursement submissions in all major European countries.
Jeroen
Jansen is the US Director of CEE and is the lead for maintaining and developing our services in the United States and Canada. Jeroen has extensive experience in evidence synthesis, including the use of Bayesian methods for network meta-analysis (mixed treatment comparisons). Furthermore, Jeroen has directed multiple economic evaluations and prepared reimbursement dossiers.
Paul Trueman has over 15 years of client-side and consulting experience. He is a member of the NICE Technology Appraisal Committee and has contributed to the development of national guidance on cancer, obesity, smoking cessation and physical activity. Here at Mapi Values Paul helps address the evolving needs of our clients, developing strategic solutions that make the most of our skills in market access landscaping, evidence generation, economic evaluation and value demonstration. |
